HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cynthia Magro Selected Research

Malignant Atrophic Papulosis

8/2022Exploring the pathophysiologic basis of constrictive pericarditis of Kohlmeier Degos disease: A case series and review of the literature.
2/2020Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cynthia Magro Research Topics

Disease

7COVID-19
06/2022 - 01/2020
6Melanoma (Melanoma, Malignant)
01/2020 - 01/2004
6Neoplasms (Cancer)
01/2017 - 01/2004
5Infections
10/2020 - 07/2008
5Inflammation (Inflammations)
04/2020 - 05/2003
4Thrombotic Microangiopathies
07/2022 - 01/2018
4Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 06/2012
3Atypical Hemolytic Uremic Syndrome
07/2022 - 06/2014
3Lymphoma (Lymphomas)
01/2022 - 09/2003
3Hypersensitivity (Allergy)
11/2021 - 12/2004
3Crohn Disease (Crohn's Disease)
10/2018 - 11/2003
2Malignant Atrophic Papulosis
08/2022 - 02/2020
2Fibrosis (Cirrhosis)
08/2022 - 08/2015
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2022 - 12/2004
2Vasculitis (Vasculitides)
11/2021 - 05/2017
2Epidermodysplasia Verruciformis
11/2021 - 06/2019
2Virus Diseases (Viral Diseases)
10/2020 - 01/2017
2Eosinophilia
04/2020 - 01/2018
2Autoimmune Diseases (Autoimmune Disease)
02/2020 - 09/2005
2Eosinophilic Fasciitis
01/2020 - 10/2019
2Pneumonia (Pneumonitis)
01/2020 - 09/2002
2Thrombosis (Thrombus)
01/2020 - 06/2014
2Papillomavirus Infections
08/2019 - 06/2019
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2018 - 08/2015
2Bacterial Infections (Bacterial Infection)
01/2017 - 08/2002
2Fistula
11/2015 - 12/2006
2Disease Progression
02/2013 - 11/2003
2Wounds and Injuries (Trauma)
08/2008 - 06/2006
2Neoplasm Metastasis (Metastasis)
12/2007 - 09/2005
2T-Cell Lymphoma (Lymphoma, T Cell)
07/2007 - 09/2003
1Pericarditis
08/2022
1Thrombocytopenia (Thrombopenia)
07/2022
1Hemolysis
07/2022
1Acute Kidney Injury (Acute Renal Failure)
07/2022
1Stevens-Johnson Syndrome (Lyell's Syndrome)
06/2022
1Linear IgA Bullous Dermatosis
06/2022
1Reactive Arthritis (Reiter Disease)
06/2022
1Hypothyroidism
01/2022
1Atopic Dermatitis (Atopic Eczema)
11/2021
1Vascular System Injuries
11/2021
1Tuberculosis (Tuberculoses)
10/2020
1Skin Diseases (Skin Disease)
07/2020
1Hyperplasia
07/2020
1Vascular Diseases (Vascular Disease)
02/2020
1Connective Tissue Diseases (Connective Tissue Disease)
02/2020

Drug/Important Bio-Agent (IBA)

7Complement System Proteins (Complement)IBA
07/2022 - 07/2008
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
6CytokinesIBA
11/2021 - 08/2002
5Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2022 - 06/2014
5Antigen-Antibody Complex (Immune Complex)IBA
11/2021 - 09/2005
4DNA (Deoxyribonucleic Acid)IBA
12/2019 - 09/2002
3Interferon Type IIBA
08/2022 - 11/2021
3AntigensIBA
11/2021 - 07/2020
3Monoclonal AntibodiesIBA
06/2014 - 09/2003
2eculizumabFDA Link
01/2022 - 06/2012
2VaccinesIBA
11/2021 - 11/2021
2Glycoproteins (Glycoprotein)IBA
11/2021 - 01/2020
2Caspase 3 (Caspase-3)IBA
04/2021 - 10/2020
2Coloring Agents (Dyes)IBA
04/2021 - 10/2020
2Indicators and Reagents (Reagents)IBA
01/2020 - 10/2019
2Immune Checkpoint InhibitorsIBA
01/2020 - 10/2019
2LigandsIBA
01/2020 - 10/2019
2Programmed Cell Death 1 ReceptorIBA
01/2020 - 10/2019
2Karyopherins (Importin)IBA
08/2019 - 06/2019
2Biomarkers (Surrogate Marker)IBA
08/2019 - 06/2019
2SteroidsIBA
01/2018 - 09/2002
2Pharmaceutical PreparationsIBA
11/2017 - 12/2004
2Infliximab (Remicade)FDA Link
11/2015 - 06/2010
2Tyrosine Kinase InhibitorsIBA
08/2015 - 09/2003
2Interferon-alpha (Interferon Alfa)IBA
09/2005 - 01/2004
12019-nCoV Vaccine mRNA-1273IBA
06/2022
1BNT162 VaccineIBA
06/2022
1Terbinafine (Lamisil)FDA LinkGeneric
06/2022
1Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022
1Bexarotene (LGD1069)FDA Link
01/2022
1Thromboplastin (Tissue Factor)IBA
01/2022
1IntegrinsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2021
1Eosine Yellowish-(YS) (Eosin)IBA
04/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2021
1Viral RNAIBA
04/2021
1Hematoxylin (Haematoxylon)IBA
04/2021
1SARS-CoV-2 envelope proteinIBA
10/2020
1ParaffinIBA
10/2020
1BCG VaccineFDA Link
10/2020
1Formaldehyde (Formol)FDA Link
10/2020
1CollagenIBA
02/2020

Therapy/Procedure

14Therapeutics
01/2020 - 09/2003
1Secondary Prevention
08/2022
1Pericardiectomy
08/2022
1Gynecologic Surgical Procedures (Gynecologic Surgery)
07/2022
1Uterine Myomectomy
07/2022
1Hematopoietic Stem Cell Transplantation
01/2022
1Heart Transplantation (Grafting, Heart)
11/2021